TR199800445A3 - cdc25B geni yükselticisi, hazirlanisi ve kullanimi. - Google Patents

cdc25B geni yükselticisi, hazirlanisi ve kullanimi.

Info

Publication number
TR199800445A3
TR199800445A3 TR1998/00445A TR9800445A TR199800445A3 TR 199800445 A3 TR199800445 A3 TR 199800445A3 TR 1998/00445 A TR1998/00445 A TR 1998/00445A TR 9800445 A TR9800445 A TR 9800445A TR 199800445 A3 TR199800445 A3 TR 199800445A3
Authority
TR
Turkey
Prior art keywords
preparation
gene amplifier
cdc25b gene
cdc25b
amplifier
Prior art date
Application number
TR1998/00445A
Other languages
English (en)
Other versions
TR199800445A2 (tr
Inventor
Koerner Kathrin
Dr. Rolf Mueller Prof.
Dr. Hans-Harald Sedlacek Prof.
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of TR199800445A2 publication Critical patent/TR199800445A2/tr
Publication of TR199800445A3 publication Critical patent/TR199800445A3/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
TR1998/00445A 1997-03-14 1998-03-12 cdc25B geni yükselticisi, hazirlanisi ve kullanimi. TR199800445A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19710643A DE19710643A1 (de) 1997-03-14 1997-03-14 Der Promotor des cdc25B Genes und seine Verwendung in der Gentherapie

Publications (2)

Publication Number Publication Date
TR199800445A2 TR199800445A2 (tr) 1999-04-21
TR199800445A3 true TR199800445A3 (tr) 1999-04-21

Family

ID=7823404

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00445A TR199800445A3 (tr) 1997-03-14 1998-03-12 cdc25B geni yükselticisi, hazirlanisi ve kullanimi.

Country Status (13)

Country Link
US (1) US6033856A (tr)
EP (1) EP0864651A3 (tr)
JP (1) JPH11181A (tr)
KR (1) KR19980080569A (tr)
AR (1) AR011458A1 (tr)
AU (1) AU739145B2 (tr)
BR (1) BR9800913A (tr)
CA (1) CA2231917A1 (tr)
CZ (1) CZ75798A3 (tr)
DE (1) DE19710643A1 (tr)
HU (1) HUP9800574A3 (tr)
PL (1) PL325362A1 (tr)
TR (1) TR199800445A3 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639103A1 (de) * 1996-09-24 1998-03-26 Hoechst Ag Nukleinsäurekonstrukte mit Hybridpromotoren für gentherapeutische Maßnahmen
DE19710643A1 (de) * 1997-03-14 1998-09-17 Hoechst Ag Der Promotor des cdc25B Genes und seine Verwendung in der Gentherapie
HUP9900956A2 (hu) 1998-04-09 2002-04-29 Aventis Pharma Deutschland Gmbh. Egyláncú, több antigéntkötőhely kialakítására képes molekulák, előállításuk és alkalmazásuk
DE19900743A1 (de) 1999-01-12 2000-07-13 Aventis Pharma Gmbh Neue komplexbildende Proteine
WO2001020034A2 (en) * 1999-09-13 2001-03-22 Basf Aktiengesellschaft Methods and compositions for the screening of cell cycle modulators
IL132446A0 (en) * 1999-10-18 2001-03-19 Genena Ltd A method for establishing connections between genes
AU2001263047A1 (en) * 2000-05-10 2001-11-20 Trustees Of Boston University Compositions and methods for treatment of proliferative disorders
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
US20030211076A1 (en) * 2001-05-10 2003-11-13 Wande Li Compositions and methods for treatment of proliferative disorders
CN1780920B (zh) * 2003-05-12 2012-03-28 波多玛克制药有限公司 基因表达抑制剂
CA2578046A1 (en) * 2004-09-07 2006-03-16 Archemix Corp. Aptamer medicinal chemistry
JP2008512098A (ja) 2004-09-07 2008-04-24 アーケミックス コーポレイション フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
EP2147105B1 (en) 2007-05-02 2013-04-24 Merial Limited Dna plasmids having improved expression and stability
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
US9719146B2 (en) * 2009-09-09 2017-08-01 General Electric Company Composition and method for imaging stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2153045T3 (es) * 1994-08-26 2001-02-16 Aventis Pharma Gmbh Terapia genica de enfermedades condicionadas por el sistema inmunologico, con ayuda de una sustancia activa especifica de la celula y regulada por el ciclo celular.
WO1996006938A1 (de) * 1994-08-26 1996-03-07 Hoechst Aktiengesellschaft Gentherapeutische behandlung von gefässerkrankungen durch einen zellspezifischen, zellzyklusabhängigen wirkstoff
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
DE19710643A1 (de) * 1997-03-14 1998-09-17 Hoechst Ag Der Promotor des cdc25B Genes und seine Verwendung in der Gentherapie

Also Published As

Publication number Publication date
DE19710643A1 (de) 1998-09-17
TR199800445A2 (tr) 1999-04-21
US6033856A (en) 2000-03-07
EP0864651A3 (de) 2000-07-26
HUP9800574A3 (en) 2003-08-28
HU9800574D0 (en) 1998-05-28
JPH11181A (ja) 1999-01-06
HUP9800574A2 (hu) 1999-03-29
AR011458A1 (es) 2000-08-16
EP0864651A2 (de) 1998-09-16
PL325362A1 (en) 1998-09-28
CZ75798A3 (cs) 1998-09-16
AU739145B2 (en) 2001-10-04
BR9800913A (pt) 1999-12-21
AU5846598A (en) 1998-09-17
CA2231917A1 (en) 1998-09-14
KR19980080569A (ko) 1998-11-25

Similar Documents

Publication Publication Date Title
TR199800445A3 (tr) cdc25B geni yükselticisi, hazirlanisi ve kullanimi.
TR199900531A3 (tr) Pirazolopirimidinler ve pirazolotriazinler.
MA25688A1 (fr) 2-thio-3, 5-dicyano-4-aryl-6-aminopyridines substituees et leur utilisation.
NO995135L (no) Fremstilling av höyaktive katalysatorer, katalysatorene og deres anvendelse
TR199501416A2 (tr) Piridazinonlar ve bunlarin fungisitler olarak kullanimi.
ZA991845B (en) Catalyst and use thereof.
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
DK0977877T3 (da) Forbedringer vedrörende genekspressionsspecificitet
EP0671470A3 (en) Enzyme releasing trehalose, DNA coding for it, their preparation and use.
HUP0104825A3 (en) Genes and proteins, and their use
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
AU1138699A (en) Dna demethylase, therapeutic and diagnostic uses thereof
DE69828382D1 (de) Informationsverarbeiter, informationsverarbeitungsverfahren und übermittlungsmedium
AP2006003504A0 (en) Outer surface proteins, their genes, and their use.
NO20003268L (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
FR2666812B1 (fr) Enzymes immobilisees, leur preparation et leur utilisation.
EP1041146A4 (en) TUMOR ANTIGEN PROTEIN, ITS GENE AND ITS USE
AU7304000A (en) Virulence gene and protein, and their use
PT991726E (pt) Corante monoazoico estavel, sua preparacao e utilizacao
AP2005003413A0 (en) Genes and proteins, and their use.
ES1038748Y (es) Estuche, especialmente para rodamientos y similares.
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
ES1039117Y (es) Cuchara-contenedor desechable, mejorada.
GB9926356D0 (en) Virulence gene and protein, and their use
GB9926347D0 (en) Virulence gene and protein, and their use